CeCelia Morken - May 22, 2025 Form 4 Insider Report for Genpact LTD (G)

Role
Director
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for CeCelia Morken
Stock symbol
G
Transactions as of
May 22, 2025
Transactions value $
$0
Form type
4
Date filed
5/27/2025, 04:59 PM
Previous filing
May 1, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morken CeCelia Director C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK /s/ Thomas D. Scholtes, as Attorney-in-fact for CeCelia Morken 2025-05-27 0001367198

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction G Common Shares Award $0 +4.83K +9.11% $0.00 57.8K May 22, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026.